Want to see SE:INIT full AI Analyst Report?
Initiator Pharma A/S (INIT) Stock Statistics & Valuation Metrics
Total Valuation
Initiator Pharma A/S has a market cap or net worth of SEK 133.14M. The enterprise value is SEK 173.87M.
- Market Cap
- SEK 133.14M
- Enterprise Value
- SEK 173.87M
Share Statistics
Initiator Pharma A/S has 68,452,890 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 68,452,890
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Initiator Pharma A/S’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -47.05%.
- Return on Equity (ROE)
- -0.47
- Return on Assets (ROA)
- -0.42
- Return on Invested Capital (ROIC)
- -47.05%
- Return on Capital Employed (ROCE)
- -0.57
- Revenue Per Employee
- 0
- Profits Per Employee
- -14.01M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Initiator Pharma A/S is -3.06. Initiator Pharma A/S’s PEG ratio is 0.05.
- PE Ratio
- -3.06
- PS Ratio
- 0.00
- PB Ratio
- 9.91
- Price to FCF
- -3.57
- Price to Operating Cash Flow
- -3.60
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Initiator Pharma A/S had revenue of 0 and earned -14.01M in profits. Earnings per share was -0.23.
- Revenue
- 0
- Gross Profit
- -14.83M
- Operating Income
- -18.20M
- Pretax Income
- -17.09M
- Net Income
- -14.01M
- EBITDA
- -18.20M
- Earnings Per Share (EPS)
- -0.23
Cash Flow
In the last 12 months, operating cash flow was -23.47M and capital expenditures 2.20M, giving a free cash flow of -23.70M billion.
- Operating Cash Flow
- -23.47M
- Free Cash Flow
- -23.70M
- Free Cash Flow per Share
- -0.35
Dividends & Yields
Initiator Pharma A/S pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -28.04%
- Earnings Yield
- -33.13%
Stock Price Statistics
- Beta
- 0.54
- 52-Week Price Change
- -38.01%
- 50-Day Moving Average
- 2.18
- 200-Day Moving Average
- 2.72
- Relative Strength Index (RSI)
- 37.35
- Average Volume (3m)
- 140.48K
Important Dates
Initiator Pharma A/S upcoming earnings date is Nov 20, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Nov 20, 2026
- Ex-Dividend Date
- ―
Financial Position
Initiator Pharma A/S as a current ratio of 25.77, with Debt / Equity ratio of 7.27%
- Current Ratio
- 25.77
- Quick Ratio
- 25.77
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 1.32
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Initiator Pharma A/S has paid -3.08M in taxes.
- Income Tax
- -3.08M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Initiator Pharma A/S EV to EBITDA ratio is -2.41, with an EV/FCF ratio of -3.25.
- EV to Sales
- 0.00
- EV to EBITDA
- -2.41
- EV to Free Cash Flow
- -3.25
- EV to Operating Cash Flow
- -3.29
Balance Sheet
Initiator Pharma A/S has SEK 17.10M in cash and marketable securities with SEK 9.69M in debt, giving a net cash position of SEK 7.42M billion.
- Cash & Marketable Securities
- SEK 17.10M
- Total Debt
- SEK 9.69M
- Net Cash
- SEK 7.42M
- Net Cash Per Share
- SEK 0.11
- Tangible Book Value Per Share
- SEK 0.12
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Initiator Pharma A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -111.93%
Scores
- Smart Score
- ―
- AI Score
- 46
